Biogen Inc.

NasdaqGS:BIIB

Sector

🏥 Health Care

Industries

🧬 Biotechnology

🔬 Clinical Trials

💊 Pharmaceuticals

Location

United States

Market Cap

USD 18.77 B

Share Price

USD 128.00

Avg Daily Volume

1,488,264

Change (1 day)

-2.04%

Change (1 year)

-36.63%

Change (YTD)

-16.30%

Biogen Inc. Return on Equity (ROE) for the Trailing 12 Months (TTM) ending June 30, 2025: 9.04%

Biogen Inc. Return on Equity (ROE) is 9.04% for the Trailing 12 Months (TTM) ending June 30, 2025, a 17.85% change year over year. Return on equity measures profit against shareholder equity; higher ROE indicates superior profitability and value creation.

Biogen Inc. Return on Equity (ROE) for the Trailing 12 Months (TTM) ending June 30, 2024 was 7.67%, a -60.80% change year over year.
Biogen Inc. Return on Equity (ROE) for the Trailing 12 Months (TTM) ending June 30, 2023 was 19.58%, a 5.64% change year over year.
Biogen Inc. Return on Equity (ROE) for the Trailing 12 Months (TTM) ending June 30, 2022 was 18.53%, a 3.62% change year over year.
Biogen Inc. Return on Equity (ROE) for the Trailing 12 Months (TTM) ending June 30, 2021 was 17.89%, a -61.37% change year over year.